CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 902690-903006 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/68a7101a90454172c91785d8c352f776a82df5d4","sourcedb":"CORD-19","sourceid":"68a7101a90454172c91785d8c352f776a82df5d4","text":"Prevalence was calculated on the presence of one positivity in the three years followed; overall it was 48.19% (80 on 166); it was slightly higher in patients with COP (59%) and low dose IFN (57%); slightly lower in those with full dose IFN (43%); and significantly lower (10%) in those with immunosuppression (MIX).","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T71720","span":{"begin":0,"end":316},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T71720","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T111","span":{"begin":0,"end":316},"obj":"Sentence"}],"attributes":[{"subj":"T111","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5640","span":{"begin":164,"end":167},"obj":"Disease"},{"id":"T48048","span":{"begin":164,"end":167},"obj":"Disease"}],"attributes":[{"id":"A5640","pred":"mondo_id","subj":"T5640","obj":"http://purl.obolibrary.org/obo/MONDO_0015264"},{"id":"A28708","pred":"mondo_id","subj":"T48048","obj":"http://purl.obolibrary.org/obo/MONDO_0015264"},{"subj":"T5640","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T48048","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93aaec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#c4ec93"},{"id":"CORD-19-PD-MONDO","color":"#ec93de"}]}]}}